Hostname: page-component-848d4c4894-4hhp2 Total loading time: 0 Render date: 2024-05-17T08:01:17.330Z Has data issue: false hasContentIssue false

Depressive symptoms in chronic schizophrenia patients: any differences between patients with and without a major depressive episode?

Published online by Cambridge University Press:  16 April 2020

Yasuhiro Kaneda*
Affiliation:
Psychopharmacology Division, Psychiatric Hospital at Vanderbilt, 1601, 23rd Avenue South, Suite 306, Nashville, TN 37212, USA Department of Neuropsychiatry, The University of Tokushima, School of Medicine Tokushima, Japan
*
*Corresponding author. E-mail address: kaneday@clin.med.tokushima-u.ac.jp
Get access

Abstract

The author investigated the differences between schizophrenia patients with and without a major depressive episode (MDE) using the Japanese Calgary Depression Scale for Schizophrenics. The total depression score was correlated with the dosage of antipsychotics in patients without an MDE, but such a correlation was not found in patients with an MDE.

Type
Short communication
Copyright
Copyright © Éditions scientifiques et médicales Elsevier SAS 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Addington, D, Addington, J, Schissel, B. A depression rating scale for schizophrenics. Schizophr Res 1990;3:247–51.CrossRefGoogle ScholarPubMed
American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM). 4th. Washington, DC: American Psychiatric Association; 1994.Google Scholar
Barnes, TR, Curson, DA, Liddle, PF, Patel, M. The nature and prevalence of depression in chronic schizophrenic in-patients. Br J Psychiatry 1989;154:486–91.CrossRefGoogle ScholarPubMed
Bressan, RA, Costa, DC, Jones, HM, Ell, PJ, Pilowsky, LS. Typical antipsychotic drugs—D(2) receptor occupancy and depressive symptoms in schizophrenia. Schizophr Res 2002;56:31–6.CrossRefGoogle Scholar
Coryell, W, Zimmerman, M. Diagnosis and outcome in schizoaffective depression: a replication. JAffect Disord 1988;15:21–7.CrossRefGoogle Scholar
Galdi, J. The causality of depression in schizophrenia. Br J Psychiatry 1983;142:621–4.Google Scholar
Inada, T. Evaluation and diagnosis of drug-induced extrapyramidal symptoms: commentary on the DIEPSS and guide to its usage (in Japanese). Tokyo: Seiwa Shoten Co., Ltd; 1996.Google Scholar
Kaneda, Y, Fujii, A, Ohmori, T. Psychometric properties of the Japanese version of the Calgary Depression Scale for Schizophrenics. J Nerv Ment Dis 2000;188:237–9.CrossRefGoogle ScholarPubMed
Kaneda, Y, Fujii, A, Okura, M, Nagamine, I. Depressive symptoms in medicated chronic schizophrenics. German J Psychiatry 1999;2:112.Google Scholar
Kapur, S, Mann, JJ. Role of the dopaminergic system in depression. Biol Psychiatry 1992;32:117.CrossRefGoogle ScholarPubMed
Knights, A. Hirsch, SR. “Revealed” depression and drug treatment for schizophrenia. Arch Gen Psychiatry 1981;38:806–11.CrossRefGoogle Scholar
Kulhara, P, Avasthi, A, Chadda, R, Chandiramani, K, Mattoo, SK, Kota, SK, et al.Negative and depressive symptoms in schizophrenia. Br J Psychiatry 1989;154:207–11.CrossRefGoogle Scholar
Lindenmayer, JP, Kay, SR, Plutchik, R. Multivantaged assessment of depression in schizophrenia. Psychiatry Res 1992;42:199207.CrossRefGoogle Scholar
Overall, JE, Gorham, DR. The brief psychiatric rating scale. Psychol Rep 1962;10:799812.Google Scholar
Siris, SG. Diagnosis of secondary depression in schizophrenia: implications for DSM-IV. Schizophr Bull 1991;17:7598.CrossRefGoogle ScholarPubMed
Zisook, S, McAdams, LA, Kuck, J, Harris, MJ, Bailey, A, Patterson, TL, et al.Depressive symptoms in schizophrenia. Am J Psychiatry 1999;156:1736–43.Google Scholar
Submit a response

Comments

No Comments have been published for this article.